Having established the predominant role of FTO inhibition versus ALKBH5 inhibition in m6A hypermethylation in IDH1wt glioma cells, we employed FTO-specific small-molecule inhibitors, FB23-2 and MA, to test whether pharmacologic FTO inhibition might provide a tractable treatment strategy. This evidence concerns the gene ALKBH5 and glioma.